Home 2026

Expanding Resectability and the Role of Multidisciplinary Teams in Lung Cancer Care

Erin Gillaspie, MD, speaks with Linda Martin, MD, on the most significant takeaways from the World Conference on Lung Cancer which took place in September 2026. The discussion ranges from how evolving systemic therapies are changing treatment pathways to the increased importance of multidisciplinary decision-making and comprehensive molecular testing in lung cancer care.

STS Updates

November Is Lung Cancer Awareness Month

Explore STS resources highlighting the latest advances in lung cancer research, screening, treatment, and patient care, with insights to support thoracic surgeons and their patients.

The Resilient Surgeon with Dr. Donna Hicks

#178, S5 Leading With Dignity: Building Psychological Safety in Surgery

A new podcast episode that explores how dignity, the inherent value and worth of every person, underpins psychological safety, effective leadership, and stronger teams.

63rd STS Annual Meeting

Late-breaking research submissions are now being accepted through Dec. 1, 2026. Share your high-impact research with the cardiothoracic surgery community.

STS Risk Calculators

Next-generation, mobile-friendly tools to help surgeons assess risk in real time.

Surgical Excellence After Neoadjuvant Therapy for NSCLC

The landscape in treatment of resectable lung cancers has changed dramatically in the past 10 years. In this short video, Dr. Douglas Liou highlights the prominent lung cancer studies that have informed care and new team approaches to neoadjuvant and perioperative systemic therapies. Supported by AstraZeneca

Member Voices

As an early career surgeon, I would argue that having supportive colleagues and mentors ultimately impacts long-term job satisfaction far more than salary alone.

Melanie Subramanian, MD, MPHS

Surgeon Member